Page last updated: 2024-12-06

zomepirac glucuronide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

zomepirac glucuronide: metabolite of zomepirac; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID64760
MeSH IDM0089016

Synonyms (11)

Synonym
75871-31-7
beta-d-glucopyranuronic acid, 1-(5-(4-chlorobenzoyl)-1,4-dimethyl-1h-pyrrole-2-acetate)
zomepirac glucuronide
(2s,3s,4s,5r,6s)-6-[2-[5-(4-chlorobenzoyl)-1,4-dimethylpyrrol-2-yl]acetyl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid
zomepirac acyl-o-|a-d-glucuronide
DTXSID70226775
zomepirac acyl-o-beta-d-glucuronide
(2s,3s,4s,5r,6s)-6-(2-(5-(4-chlorobenzoyl)-1,4-dimethyl-1h-pyrrol-2-yl)acetoxy)-3,4,5-trihydroxytetrahydro-2h-pyran-2-carboxylic acid
CS-0179461
1-[5-(4-chlorobenzoyl)-1,4-dimethyl-1h-pyrrole-2-acetate] beta-d-glucopyranuronic acid
zomepirac acyl-o- beta -d-glucuronide

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" Dosage adjustments may, therefore, be necessary in patients with cirrhosis of the liver."( Abnormal glucuronidation of zomepirac in patients with cirrhosis of the liver.
Bircher, J; Huguenin, P; Preisig, R; Witassek, F,
)
0.13
" ZP-modified tubulin was shown to be present in the cytosol of livers from rats dosed twice daily for 3 days with ZP at 50 mg/kg, using a sandwich ELISA with ZP and tubulin antisera."( Zomepirac acyl glucuronide covalently modifies tubulin in vitro and in vivo and inhibits its assembly in an in vitro system.
Bailey, MJ; de Jersey, J; Dickinson, RG; Worrall, S, 1998
)
0.3
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (8)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (37.50)18.7374
1990's3 (37.50)18.2507
2000's0 (0.00)29.6817
2010's2 (25.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.68

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.68 (24.57)
Research Supply Index2.64 (2.92)
Research Growth Index4.32 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.68)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other13 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]